Efficacy of lamivudine plus adefovir therapy or adefovir add on therapy for entecavir-resistant hepatitis B patients
Not Applicable
Completed
- Conditions
- Certain infectious and parasitic diseases
- Registration Number
- KCT0000085
- Lead Sponsor
- Ajou University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 37
Inclusion Criteria
ETV-refractory chronic hepatitis B patients
Exclusion Criteria
co-infections (hepatitis C virus or human immunodeficiency virus) or other concomitant liver disease such as alcoholic liver disease or autoimmune liver disease.
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HBeAg seroconversion or HBeAg loss;HBV DNA negativity
- Secondary Outcome Measures
Name Time Method ALT normalization